SESSION TITLE: Chest Infections: Bacterial
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: The optimal therapy for infections caused by Stenotrophomonas maltophilia (S. maltophilia) hasn't yet been established. The objective of our study is to evaluate the in vitro activity of trimethoprim/sulfamethoxazole (SXT), minocycline, tigecycline, moxifloxacin, levofloxacin, ticarcillin-clavulanate, chloramphenicol, polymyxin E, ceftazidime and to select for desired antimicrobial combinations against clinical isolated S. maltophilia.